<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00671281</url>
  </required_header>
  <id_info>
    <org_study_id>Tranexamic Acid in FESS</org_study_id>
    <nct_id>NCT00671281</nct_id>
  </id_info>
  <brief_title>The Effect of Tranexamic Acid on Intraoperative and Post-Operative Bleeding in Functional Endoscopic Sinus Surgery</brief_title>
  <official_title>The Effect of Tranexamic Acid on Intraoperative and Post-Operative Bleeding in Functional Endoscopic Sinus Surgery: A Randomized, Prospective, Double-Blinded Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Calgary</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Calgary</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sinus surgery is a common, day surgery procedure performed by general and subspecialty
      trained otolaryngologists. In most cases, this is a safe surgery with a low incidence of
      complications. When there is significant bleeding or enough bleeding to obscure important
      anatomical landmarks, there is a higher chance of complications. These complications can
      include blindness, meningitis or cerebrospinal fluid leak. Our hypothesis is that in patients
      taking oral tranexamic acid three days before surgery and six days after, there will be less
      intraoperative bleeding, better surgical visualization and less postoperative bleeding
      events.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Study was cancelled
  </why_stopped>
  <start_date>October 2008</start_date>
  <completion_date type="Anticipated">December 2009</completion_date>
  <primary_completion_date type="Anticipated">June 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraoperative bleeding amount</measure>
    <time_frame>During the surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical visualization scoring</measure>
    <time_frame>During the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative bleeding events</measure>
    <time_frame>Six days after the surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">74</enrollment>
  <condition>Chronic Sinusitis</condition>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will be the experimental group which will receive tranexamic acid in oral form three days before and six days after surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This will be the control group which will take the placebo medication for 3 days before and six days after their functional endoscopic sinus surgery (FESS).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tranexamic acid</intervention_name>
    <description>Oral form, 100mg, tid (three times per day), 3 days before/the day of/6 days after the surgery</description>
    <arm_group_label>B</arm_group_label>
    <other_name>Cyclokapron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo, Oral form, three times a day, 3 days before/day of/6 days after surgery</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic sinusitis requiring bilateral functional endoscopic sinus surgery

          -  Between the ages of 18-65

          -  Willing to comply with standard followup

          -  No coagulopathy

          -  Not pregnant

        Exclusion Criteria:

          -  Pregnant

          -  On anticoagulants within 3 months of the surgery

          -  Coagulopathy

          -  &lt;18 or &gt;65 years of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brad D Mechor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Otolaryngology, University of Calgary</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rockyview General Hospital</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2V 1P9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Osguthorpe JD. Surgical outcomes in rhinosinusitis: what we know. Otolaryngol Head Neck Surg. 1999 Apr;120(4):451-3.</citation>
    <PMID>10187931</PMID>
  </reference>
  <reference>
    <citation>Blumenfeld RJ, Skolnik EM. Intracranial complications of sinus disease. Trans Am Acad Ophthalmol Otolaryngol. 1966 Nov-Dec;70(6):899-908.</citation>
    <PMID>5971474</PMID>
  </reference>
  <reference>
    <citation>Clayman GL, Adams GL, Paugh DR, Koopmann CF Jr. Intracranial complications of paranasal sinusitis: a combined institutional review. Laryngoscope. 1991 Mar;101(3):234-9.</citation>
    <PMID>2000009</PMID>
  </reference>
  <reference>
    <citation>Morgan PR, Morrison WV. Complications of frontal and ethmoid sinusitis. Laryngoscope. 1980 Apr;90(4):661-6.</citation>
    <PMID>7359985</PMID>
  </reference>
  <reference>
    <citation>Cumberworth VL, Sudderick RM, Mackay IS. Major complications of functional endoscopic sinus surgery. Clin Otolaryngol Allied Sci. 1994 Jun;19(3):248-53.</citation>
    <PMID>7923850</PMID>
  </reference>
  <reference>
    <citation>Goldwyn RM. Unexpected bleeding after elective nasal surgery. Ann Plast Surg. 1979 Mar;2(3):201-4.</citation>
    <PMID>539747</PMID>
  </reference>
  <reference>
    <citation>Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999 Jun;57(6):1005-32. Review.</citation>
    <PMID>10400410</PMID>
  </reference>
  <reference>
    <citation>Yaniv E, Shvero J, Hadar T. Hemostatic effect of tranexamic acid in elective nasal surgery. Am J Rhinol. 2006 Mar-Apr;20(2):227-9.</citation>
    <PMID>16686395</PMID>
  </reference>
  <reference>
    <citation>Fremes SE, Wong BI, Lee E, Mai R, Christakis GT, McLean RF, Goldman BS, Naylor CD. Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding. Ann Thorac Surg. 1994 Dec;58(6):1580-8.</citation>
    <PMID>7526811</PMID>
  </reference>
  <reference>
    <citation>Casati V, Sandrelli L, Speziali G, Calori G, Grasso MA, Spagnolo S. Hemostatic effects of tranexamic acid in elective thoracic aortic surgery: a prospective, randomized, double-blind, placebo-controlled study. J Thorac Cardiovasc Surg. 2002 Jun;123(6):1084-91.</citation>
    <PMID>12063454</PMID>
  </reference>
  <reference>
    <citation>Wormald PJ, van Renen G, Perks J, Jones JA, Langton-Hewer CD. The effect of the total intravenous anesthesia compared with inhalational anesthesia on the surgical field during endoscopic sinus surgery. Am J Rhinol. 2005 Sep-Oct;19(5):514-20.</citation>
    <PMID>16270608</PMID>
  </reference>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 30, 2008</study_first_submitted>
  <study_first_submitted_qc>May 4, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2008</study_first_posted>
  <last_update_submitted>September 2, 2010</last_update_submitted>
  <last_update_submitted_qc>September 2, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 3, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr. Brad Mechor</name_title>
    <organization>Division of Otolaryngology, University of Calgary</organization>
  </responsible_party>
  <keyword>FESS</keyword>
  <keyword>Tranexamic acid</keyword>
  <keyword>Hemostasis</keyword>
  <keyword>Visualization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
    <mesh_term>Postoperative Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tranexamic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

